Clinical Control Study of Immunotherapy and Concurrent Chemoradiotherapy in Patients With Esophageal Cancer Recurrence

NCT04404491 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

240

Enrollment

OTHER

Sponsor class

Conditions

Esophageal Malignant Neoplasm, Local Recurrence

Interventions

DRUG: Procedural death 1
DRUG: Capecitabine
RADIATION: Radiotherapy
DRUG: Placebo

Sponsor

The First Affiliated Hospital of Henan University of Science and Technology